Detalhe da pesquisa
1.
Utility of prophylactic percutaneous endoscopic gastrostomy tube in head and neck cancer patients undergoing concurrent chemoradiation: A prospective observational cohort.
Am J Otolaryngol
; 43(4): 103512, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35636089
2.
Benefits of prophylactic percutaneous gastrostomy in patients with nasopharyngeal cancer receiving concurrent chemoradiotherapy: A multicenter analysis.
Am J Otolaryngol
; 43(2): 103356, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972008
3.
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6.
Lancet Oncol
; 16(7): 830-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26051236
4.
Cerebral venous thrombosis: comparing characteristics of infective and non-infective aetiologies: a 12-year retrospective study.
Postgrad Med J
; 91(1082): 670-4, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26499451
5.
Predictors of hospital outcome in patients with cerebral venous thrombosis.
J Stroke Cerebrovasc Dis
; 23(10): 2725-2729, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25307433
6.
Blood Eosinophil Count Stability and Clinical Outcomes in Patients With Chronic Obstructive Pulmonary Disease in a High Endemic Area of Parasitic Infection: A Prospective Study.
Chronic Obstr Pulm Dis
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575373
7.
Prevalence, associated factors, and clinical consequences of metabolic syndrome in chronic obstructive pulmonary disease patients: a 5-year prospective observational study.
Ther Adv Respir Dis
; 17: 17534666231167342, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086118
8.
Prevalence, predictors, dynamic bone change, and treatment efficacy of osteoporosis among chronic obstructive pulmonary disease patients: a prospective cohort study.
Front Med (Lausanne)
; 10: 1214277, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614952
9.
Predictive and Prognostic Value of TUBB3, RRM1, APE1, and Survivin Expression in Chemotherapy-Receiving Patients with Advanced NonSmall Cell Lung Cancer.
Asian Pac J Cancer Prev
; 24(9): 3003-3013, 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774051
10.
Validation of the prognostic scoring system for in-hospital mortality prediction in cardiogenic shock patients requiring veno-arterial extracorporeal membrane oxygenation.
Asian Cardiovasc Thorac Ann
; 31(4): 321-331, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036252
11.
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.
J Clin Oncol
; 41(6): 1213-1227, 2023 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327426
12.
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations.
J Clin Oncol
; 41(16): 2869-2876, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37235976
13.
Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
Lung Cancer
; 186: 107422, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992595
14.
Acinetobacter baumannii nosocomial pneumonia in tertiary care hospitals in Thailand.
J Med Assoc Thai
; 95 Suppl 2: S23-33, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22574526
15.
Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand.
J Pathol Transl Med
; 56(3): 126-133, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35209701
16.
Diagnostic and prognostic value of serum miR-145 and vascular endothelial growth factor in non-small cell lung cancer.
Oncol Lett
; 23(1): 12, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34820011
17.
Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study.
Clin Nutr
; 41(2): 433-440, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007812
18.
Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer (MYSTIC).
Clin Lung Cancer
; 22(4): 301-312.e8, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33775558
19.
Serum miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer.
PLoS One
; 15(10): e0241593, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33125430
20.
Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
Cancer Biol Med
; 17(3): 652-663, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32944397